Colgate-PalmoliveCoca-Cola Europacific Partners

Colgate-Palmolive vs Coca-Cola Europacific Partners

Global oral care leader with steady household sales vs Major bottler of Coca-Cola drinks across Europe and Asia. Which is the better buy for your portfolio in November 2026? Plain-English answer below.

Colgate-Palmolive vs Coca-Cola Europacific Partners sets a household staples giant against a major bottling and distribution powerhouse, two companies that depend on massive operational scale and deep...

Why It’s Moving

Colgate-Palmolive

Colgate-Palmolive Shares Rally on Strong Q3 Beat and Analyst Upgrades Despite Valuation Concerns

  • Q3 earnings beat expectations with revenues growing 3.6% organically, supported by strong momentum in emerging markets and premium product innovation.
  • Analysts have boosted forecasts following the upbeat report, citing margin expansion and robust free cash flow generation of $3.8 billion over the trailing twelve months.
  • The company narrowed its sales guidance range while raising profitability expectations, reinforcing confidence in its pricing power against rising inflation.
Sentiment:
🐃Bullish
Coca-Cola Europacific Partners

CCEP Resilience Tested: Cost Pressures Offset Strong Q3 Volume Growth

  • Revenue grew 5.8% on a comparable, foreign-exchange-neutral basis, supported by a 3.6% increase in volume and higher revenue per unit case.
  • CEO Damian Gammell highlighted balanced performance across regions, channels, and product categories, signaling operational stability despite macro headwinds.
  • Management flagged emerging cost pressures from geopolitical tensions but emphasized resilience through tight spending controls and productivity gains.
Sentiment:
⚖️Neutral

Investment Analysis

Pros

  • Colgate-Palmolive achieved organic sales growth of 2.4% in Q2 2025, demonstrating resilience despite inflation and foreign exchange headwinds.
  • The company maintains a strong global market position in household and personal care products, supported by high gross profit margins of over 60%.
  • Colgate-Palmolive offers a stable dividend yield of around 2.7%, appealing to income-focused investors seeking consistent returns.

Considerations

  • The stock trades at a premium valuation, with a P/E ratio above sector average, which may limit upside for new investors.
  • Recent analyst price targets have been lowered, reflecting concerns about future growth and limited share price appreciation over the past year.
  • Colgate-Palmolive faces ongoing exposure to raw material cost pressures and currency volatility, which could impact profitability.

Pros

  • Coca-Cola Europacific Partners benefits from strong brand recognition and a dominant position in the European and Pacific beverage markets.
  • The company has demonstrated consistent revenue growth, supported by a diversified product portfolio and strategic distribution networks.
  • It maintains healthy operating margins and a solid return on equity, reflecting efficient capital allocation and operational discipline.

Considerations

  • The business is exposed to regulatory risks and changing consumer preferences, particularly around sugar content and health concerns.
  • Coca-Cola Europacific Partners faces competitive pressures from both global and local beverage brands, which could constrain pricing power.
  • The company's performance is sensitive to macroeconomic factors, including inflation and currency fluctuations, especially in its international markets.

Colgate-Palmolive (CL) Next Earnings Date

The next earnings date for CL has not been confirmed yet, with the most recent report released on 2026-11-01. Based on the company's historical reporting pattern of approximately three-month intervals, the upcoming release is expected in early February 2027. This forthcoming report will cover the fourth quarter of fiscal year 2026.

Coca-Cola Europacific Partners (CCEP) Next Earnings Date

CCEP’s next scheduled earnings-related update is November 3, 2026. It is expected to cover the company’s third quarter of fiscal 2026. The release is likely to be a Q3 trading update rather than a full quarterly earnings report, consistent with CCEP’s reporting pattern.

Buy CL or CCEP in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions